Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Cells derived from regenerated endothelium of the porcine coronary artery contain more oxidized forms of apolipoprotein-B-100 without a modification in the uptake of oxidized LDL.

Kennedy S, Fournet-Bourguignon MP, Breugnot C, Castedo-Delrieu M, Lesage L, Reure H, Briant C, Leonce S, Vilaine JP, Vanhoutte PM.

J Vasc Res. 2003 Jul-Aug;40(4):389-98. Epub 2003 Aug 6.

PMID:
12904688
2.

Persistence of the nitric oxide pathway in the aorta of hypercholesterolemic apolipoprotein-E-deficient mice.

Villeneuve N, Fortuno A, Sauvage M, Fournier N, Breugnot C, Jacquemin C, Petit C, Gosgnach W, Carpentier N, Vanhoutte P, Vilaine JP.

J Vasc Res. 2003 Mar-Apr;40(2):87-96.

PMID:
12808344
3.

Hypercholesterolemia increases coronary endothelial dysfunction, lipid content, and accelerated atherosclerosis after heart transplantation.

Perrault LP, Mahlberg F, Breugnot C, Bidouard JP, Villeneuve N, Vilaine JP, Vanhoutte PM.

Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):728-36.

PMID:
10712398
4.

Usefulness of modified Dixon's medium for quantitative culture of Malassezia species from canine skin.

Guillot J, Breugnot C, de Barros M, Chermette R.

J Vet Diagn Invest. 1998 Oct;10(4):384-6. No abstract available.

PMID:
9786534
5.

The role of p53 as a transcription factor in the induction of apoptosis.

Yonish-Rouach E, Choisy C, Deguin V, Breugnot C, May E.

Behring Inst Mitt. 1996 Oct;(97):60-71. Review.

PMID:
8950467
6.

Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53.

Yonish-Rouach E, Deguin V, Zaitchouk T, Breugnot C, Mishal Z, Jenkins JR, May E.

Oncogene. 1995 Dec 7;11(11):2197-205.

PMID:
8570169
7.

Synthesis and evaluation of 3',5'-di-tert-butyl-4'-hydroxyflavones as potential inhibitors of low density lipoprotein (LDL) oxidation.

Lewin G, Rolland Y, Privat S, Breugnot C, Lenaers A, Vilaine JP, Baltaze JP, Poisson J.

J Nat Prod. 1995 Dec;58(12):1840-7.

PMID:
8691205
8.

[Non-hypertensive desoxycorticosterone treatment enhances the progression of atherosclerosis in WHHL rabbit].

Villeneuve N, Janiak P, Brunel-Jacquemin C, Canovi C, Pillon A, Breugnot C, Gransagne D, Vilaine JP.

Arch Mal Coeur Vaiss. 1995 Aug;88(8):1197-201. French.

PMID:
8572873
9.

Non-hypertensive deoxycorticosterone-salt treatment accelerates atherosclerosis progression in Watanabe heritable hyperlipidemic rabbit.

Janiak P, Villeneuve N, Pillon A, Jacquemin C, Breugnot C, Gransagne D, Vilaine JP.

J Vasc Res. 1994 Nov-Dec;31(6):347-58.

PMID:
7986959
10.

S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.

Breugnot C, Privat S, Guillonneau C, Regnier G, Bouzom F, Vilaine JP, Lenaers A.

J Pharmacol Exp Ther. 1994 May;269(2):515-20.

PMID:
8182520
11.

Human transforming growth factor alpha: sequence analysis of the 4.5-kb and 1.6-kb mRNA species.

Qian JF, Lazar-Wesley E, Breugnot C, May E.

Gene. 1993 Oct 15;132(2):291-6.

PMID:
8224876
12.

In vitro and ex vivo inhibition of the modification of low-density lipoprotein by indapamide.

Breugnot C, Iliou JP, Privat S, Robin F, Vilaine JP, Lenaers A.

J Cardiovasc Pharmacol. 1992 Sep;20(3):340-7.

PMID:
1279277
13.

Calcium antagonists prevent monocyte and endothelial cell-induced modification of low density lipoproteins.

Breugnot C, Mazière C, Auclair M, Mora L, Ronveaux MF, Salmon S, Santus R, Morlière P, Lenaers A, Mazière JC.

Free Radic Res Commun. 1991;15(2):91-100.

PMID:
1756990
15.

Phenothiazines inhibit copper and endothelial cell-induced peroxidation of low density lipoprotein. A comparative study with probucol, butylated hydroxytoluene and vitamin E.

Breugnot C, Mazière C, Salmon S, Auclair M, Santus R, Morlière P, Lenaers A, Mazière JC.

Biochem Pharmacol. 1990 Nov 1;40(9):1975-80.

PMID:
2242028
16.

Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein.

Soussi T, Caron de Fromentel C, Breugnot C, May E.

Nucleic Acids Res. 1988 Dec 9;16(23):11384. No abstract available.

Supplemental Content

Loading ...
Support Center